Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis

Crit Care. 2005;9(6):R596-600. doi: 10.1186/cc3808. Epub 2005 Sep 19.

Abstract

Introduction: In acute disseminated intravascular coagulation, the effect of antithrombin (AT) administration on elevated levels of D-dimer is not well established. In the present study, we report on changes in circulating levels of D-dimer in response to administration of AT in a series of patients with acquired AT deficiency due to severe sepsis.

Methods: Eight consecutive critically ill medical patients presenting with acute disseminated intravascular coagulation associated with severe sepsis/septic shock received a single bolus infusion of AT over 30 minutes, aiming to achieve physiological AT levels. Haemostatic parameters including D-dimer were assessed prior to, 6 and 24 h after AT administration. An average of 42 +/- 9 U/kg body weight was infused.

Results: Following AT substitution, elevated levels of D-dimer fell whereas AT levels rose.

Conclusion: These observations support the notion that AT can favourably affect fibrin degradation accompanying disseminated intravascular coagulation of severe sepsis.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Antithrombins / deficiency*
  • Antithrombins / therapeutic use*
  • Critical Care / methods
  • Critical Illness
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Fibrin Fibrinogen Degradation Products / drug effects*
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Heparin / therapeutic use
  • Humans
  • Middle Aged
  • Sepsis / blood*
  • Sepsis / complications*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Antithrombins
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Heparin